Food and Drug Administration
The results of a long-term major federal study that was done in Texas is easing worries about the safety of a hormone-blocking drug that can lower a man’s chances of developing prostate cancer.
A mother and son from Midlothian who say they were sickened at a restaurant in Lincoln, Nebraska have filed a lawsuit against the company that owns Olive Garden restaurants in a Nebraska court.
Consumers are going to know exactly what they’re getting when they buy foods labeled “gluten free.” The Food and Drug Administration is defining what the “gluten free” label really means.
Hair loss is one of chemotherapy’s most noticeable and despised side effects. Now U.S. researchers are about to put an experimental hair-preserving treatment to a rigorous test.
In a matter of weeks, the so called ‘morning-after pill’ will be made available to anyone with the money to buy it—including very young girls.
A federal judge has ruled the Food and Drug Administration must offer the so-called “morning after” pill over the counter to women of all ages regardless of age limits.
Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs.
Increased awareness and use of electronic cigarettes in the U.S. outlined in a study released Thursday highlights the need for government regulation and evaluation, the head of the CDC says.
The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.
The makers of Ambien and similar sleeping pills will be required to lower the dosage of their drugs due to studies suggesting patients face a higher risk of injury due to morning drowsiness.
Talk about a smoke break. Tobacco companies have introduced almost no new cigarettes or smokeless tobacco products in the U.S. in more than 18 months because the federal government has prevented them from doing so.
The Food and Drug Administration has expanded approval of Johnson & Johnson’s prostate cancer pill Zytiga for men with an earlier stage of the disease.